Preoperative Radiotherapy versus postoperative Radiotherapy after neoadjuvant Chemotherapy ("NeoRad") in High-risk Breast Cancer: a prospective, randomized, international multicenter Phase III Study

被引：0
|
作者：
Matuschek, Christiane [1 ]
Jazmati, Danny [2 ]
Krug, David [3 ]
Corradini, Stefanie [4 ]
Fehm, Tanja [5 ]
Ruckhaeberle, Eugen [5 ]
Kuehn, Thorsten [6 ]
Stickeler, Elmar [7 ]
Nestle-Kraemling, Carolin [8 ]
Holtschmidt, Johannes [9 ]
Nekljudova, Valentina [9 ]
Loibl, Sibylle [9 ]
Budach, Wilfried [2 ]
机构：
[1] Univ Bielefeld, Med Fak,Univ klin OWL, Univ klin Strahlentherapie & Radioonkol, Campus Klin Bielefeld, Teutoburger Str 50, D-33604 Bielefeld, Germany
[2] Heinrich Heine Univ Dusseldorf, Med Fak, Klin Strahlentherapie & Radiol Onkol, Dusseldorf, Germany
[3] Univ klin Hamburg Eppendorf, Klin Strahlentherapie, Klin Strahlentherapie & Radioonkol, MVZ, Hamburg, Germany
[4] LMU Munchen, Klin Radioonkol, Munich, Germany
[5] Univ klin Dusseldorf, Med Fak, Frauenklin, CIO ABCD, Dusseldorf, Germany
[6] Filderklin Stuttgart, Stuttgart, Germany
[7] Uniklin Aachen, Frauenklin, CIO ABCD, Aachen, Germany
[8] EVK Dusseldorf, Dusseldorf, Germany
[9] German Breast Grp, Neu Isenburg, Germany
来源：
ONKOLOGIE | 2024年 / 30卷 / 09期
关键词：
Brustkrebs; Bestrahlung; Neoadjuvanz; Krankheitsfreies uberleben; Nebenwirkungen; RADIATION-THERAPY;
D O I：
10.1007/s00761-024-01568-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：840 / 844
页数：5
相关论文
共 50 条
  • [21] PHASE II STUDY OF VINORELBINE AND ESTRAMUSTINE IN COMBINATION WITH CONFORMATIONAL RADIOTHERAPY FOR PATIENTS WITH HIGH-RISK PROSTATE CANCER
    Carles, Joan
    Nogue, Miguel
    Sole, Josep M.
    Foro, Palmira
    Domenech, Montserrat
    Suarez, Marta
    Gallardo, Enrique
    Garcia, Dario
    Ferrer, Ferran
    Gelabert-Mas, Antoni
    Gayo, Javier
    Fabregat, Xavier
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (04): : 1085 - 1091
  • [22] Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial
    Tang, Ling-Long
    Chen, Lin
    Xu, Gui-Qiong
    Zhang, Ning
    Huang, Cheng-Long
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhou, Guan-Qun
    Lei, Feng
    Chen, Lu-Si
    Huang, Shao Hui
    Chen, Lei
    Chen, Yu-Pei
    Zhang, Yuan
    Liu, Xu
    Xu, Cheng
    Zhao, Yin
    Li, Ji-Bin
    Liu, Na
    Xie, Fang-Yun
    Guo, Rui
    Sun, Ying
    Ma, Jun
    CA-A CANCER JOURNAL FOR CLINICIANS, 2025,
  • [23] Neoadjuvant LHRH analog plus estramustine phosphate combined with three-dimensional conformal radiotherapy for intermediate- to high-risk prostate cancer: a randomized study
    Hirano, Daisaku
    Nagane, Yusuke
    Satoh, Katsuhiko
    Mochida, Junichi
    Sugimoto, Shuji
    Ichinose, Taketo
    Takahashi, Satoru
    Maebayashi, Toshiya
    Saitoh, Tsutomu
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (01) : 81 - 88
  • [24] Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
    Koenig, Laila
    Jaekel, Cornelia
    Doeberitz, Nikolaus von Knebel
    Kieser, Meinhard
    Eberle, Fabian
    Muenter, Marc
    Debus, Juergen
    Herfarth, Klaus
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [25] Location of recurrences in high-risk stage I endometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study
    Ortoft, Gitte
    Hogdall, Claus
    Juhl, Caroline
    Petersen, Lone K.
    Hansen, Estrid S.
    Dueholm, Margit
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (03) : 497 - 504
  • [26] Neoadjuvant chemotherapy associated with isotoxic high-dose stereotactic body radiotherapy does not increase postoperative complications after pancreaticoduodenectomy for nonmetastatic pancreatic cancer
    Navez, Julie
    Bouchart, Christelle
    Mans, Laura
    Devos, Soline
    Loi, Patrizia
    Closset, Jean
    Van Laethem, Jean-Luc
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (01) : 33 - 40
  • [27] Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial
    Chen, Si-Ye
    Sun, Guang-Yi
    Tang, Yu
    Jing, Hao
    Song, Yong-Wen
    Jin, Jing
    Liu, Yue-Ping
    Zhao, Xu-Ran
    Song, Yu-Chun
    Chen, Bo
    Qi, Shu-Nan
    Tang, Yuan
    Lu, Ning-Ning
    Li, Ning
    Fang, Hui
    Li, Ye-Xiong
    Wang, Shu-Lian
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : 153 - 164
  • [28] Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial (vol 376, pg 91, 2010)
    Vaidya, J. S.
    Joseph, D. J.
    Tobias, J. S.
    LANCET, 2010, 376 (9735) : 90 - 90
  • [29] FINAL REPORT OF MULTICENTER CANADIAN PHASE III RANDOMIZED TRIAL OF 3 VERSUS 8 MONTHS OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY BEFORE CONVENTIONAL-DOSE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Crook, Juanita
    Ludgate, Charles
    Malone, Shawn
    Perry, Gad
    Eapen, Libni
    Bowen, Julie
    Robertson, Susan
    Lockwood, Gina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 327 - 333
  • [30] Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker
    Jiang, Wen
    Chen, Lan
    Li, Rongrong
    Li, Jiang
    Dou, Shengjin
    Ye, Lulu
    He, Yining
    Tian, Zhen
    Yao, Yanli
    Zhu, Guopei
    BMC MEDICINE, 2024, 22 (01):
12345